Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Leukemia & Lymphoma
|
May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>
Jennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2016
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review
Chelsea C Pinnix, Jatin J Shah, Hubert Chuang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
Jason Westin, R Eric Davis, Lei Feng, et al.
Nature Medicine
|
October 6, 2020
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla-Osorio, et al.
The Lancet. Haematology
|
June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Jillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2025
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial
Lihua E Budde, Huilai Zhang, Won-Seog Kim, et al.
Blood
|
February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Paolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Cell Reports. Medicine
|
November 17, 2022
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma
Johannes F Fahrmann, Neeraj Y Saini, Chang Chia-Chi, et al.
Blood Advances
|
July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Leukemia & Lymphoma
|
May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>
Jennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2016
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review
Chelsea C Pinnix, Jatin J Shah, Hubert Chuang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
Jason Westin, R Eric Davis, Lei Feng, et al.
Nature Medicine
|
October 6, 2020
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla-Osorio, et al.
The Lancet. Haematology
|
June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
Jillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2025
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial
Lihua E Budde, Huilai Zhang, Won-Seog Kim, et al.
Blood
|
February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Paolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Cell Reports. Medicine
|
November 17, 2022
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma
Johannes F Fahrmann, Neeraj Y Saini, Chang Chia-Chi, et al.
Blood Advances
|
July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Page
of 10